Prognostic significance of pretreatment 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with T2N1 hormone receptor-positive, ERBB2-negative breast cancer who underwent adjuvant chemotherapy.
Sangwon HanSae Byul LeeGyungyub GongJungbok LeeSun Young ChaeJungsu S OhDae Hyuk MoonPublished in: Breast cancer research and treatment (2023)
F-FDG PET/CT was independently associated with reduced long-term IDFS in T2N1 HR-positive ERBB2-negative breast cancer patients who underwent adjuvant chemotherapy.